tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXEL Stock Latest News

Exelixis director buys $1.2M in common stock
The FlyExelixis director buys $1.2M in common stock
10d ago
EXEL
Exelixis initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
Exelixis initiated with a Peer Perform at Wolfe Research
19d ago
EXEL
Exelixis Announces Leadership Transition with New General Counsel
PremiumCompany Announcements
Exelixis Announces Leadership Transition with New General Counsel
29d ago
8K
EXEL
Exelixis price target raised to $45 from $44 at Morgan Stanley
PremiumThe Fly
Exelixis price target raised to $45 from $44 at Morgan Stanley
29d ago
EXEL
Exelixis price target raised to $40 from $35 at UBS
PremiumThe Fly
Exelixis price target raised to $40 from $35 at UBS
1M ago
EXEL
Exelixis’ Earnings Call: Strong Growth Amid Challenges
PremiumCompany AnnouncementsExelixis’ Earnings Call: Strong Growth Amid Challenges
1M ago
EXEL
Exelixis price target raised to $49 from $46 at H.C. Wainwright
Premium
The Fly
Exelixis price target raised to $49 from $46 at H.C. Wainwright
1M ago
EXEL
Exelixis price target raised to $51 from $44 at TD Cowen
Premium
The Fly
Exelixis price target raised to $51 from $44 at TD Cowen
1M ago
EXEL
Exelixis price target raised to $43 from $41 at Stifel
PremiumThe Fly
Exelixis price target raised to $43 from $41 at Stifel
1M ago
EXEL
Exelixis price target raised to $41 from $40 at Barclays
PremiumThe Fly
Exelixis price target raised to $41 from $40 at Barclays
1M ago
EXEL
Exelixis’s Strong Financial Performance and Growth Prospects Earns Buy Rating from Yaron Werber
PremiumRatings
Exelixis’s Strong Financial Performance and Growth Prospects Earns Buy Rating from Yaron Werber
1M ago
EXEL
Exelixis Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Exelixis Reports Strong Q3 2025 Financial Results
1M ago
EXEL
Exelixis: Strong Growth Prospects and Strategic Focus Justify Buy Rating
PremiumRatingsExelixis: Strong Growth Prospects and Strategic Focus Justify Buy Rating
1M ago
EXEL
Exelixis Announces $750 Million Stock Repurchase Program
Premium
Company Announcements
Exelixis Announces $750 Million Stock Repurchase Program
1M ago
8K
EXEL
Exelixis reports Q3 adjusted EPS 81c, consensus 67c
Premium
The Fly
Exelixis reports Q3 adjusted EPS 81c, consensus 67c
1M ago
EXEL
Exelixis reports Q3 EPS 78c, consensus 67c
PremiumThe Fly
Exelixis reports Q3 EPS 78c, consensus 67c
1M ago
EXEL
Exelixis downgraded to Neutral at Guggenheim after stock nearly doubling
PremiumThe Fly
Exelixis downgraded to Neutral at Guggenheim after stock nearly doubling
1M ago
EXEL
Exelixis downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Exelixis downgraded to Neutral from Buy at Guggenheim
1M ago
EXEL
EXEL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EXEL Earnings this Week: How Will it Perform?
1M ago
EXEL
Exelixis’s Strategic Positioning and Market Prospects Justify Buy Rating Amid RCC Treatment Dynamics
PremiumRatingsExelixis’s Strategic Positioning and Market Prospects Justify Buy Rating Amid RCC Treatment Dynamics
1M ago
EXEL
Buy Rating Affirmed for Exelixis: Promising Phase 3 Trial Results and Favorable Valuation Despite Safety Concerns
Premium
Ratings
Buy Rating Affirmed for Exelixis: Promising Phase 3 Trial Results and Favorable Valuation Despite Safety Concerns
1M ago
EXEL
Apple, MARA, Exelixis, Strategy, Dell: Trending by Analysts
Premium
Weekend Updates
Apple, MARA, Exelixis, Strategy, Dell: Trending by Analysts
1M ago
AAPL
DELL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >